Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8032777 | 0.92 | MAPT (0.47) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL8032990 | 0.92 | NPC1 (0.48) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL29462117 | 0.83 | MAPT (0.55) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL261845 | 0.83 | MAPT (0.55) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL1802604 | 0.81 | NPC1 (0.55) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL13473966 | 0.81 | MAPT (0.71) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL21315445 | 0.79 | MEN1 (0.54) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL28312216 | 0.79 | NPC1 (0.58) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL20274482 | 0.78 | NPC1 (0.50) | NPC1RAB9ALMNAMAPK1MAPT | |
| SCHEMBL13178023 | 0.78 | MAPT (0.64) | NPC1RAB9ALMNAMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4519721-B1 | RADIATION BLOCKERS FOR CONTACT LENSES | COOPERVISION INT LTD (GB) | 2025-10-01 | — | — | EP | claimed |
| WO-2023228055-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-30 | — | — | WO | claimed |
| US-20230374306-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-23 | — | — | US | claimed |
| US-11372267-B2 | Contact lens product | LARGAN MEDICAL CO., LTD. (TW) | 2022-06-28 | — | — | US | claimed |
| US-20200150460-A1 | CONTACT LENS PRODUCT | LARGAN MEDICAL CO., LTD. (TW) | 2020-05-14 | — | — | US | claimed |
| US-10578889-B2 | Contact lens product | LARGAN MEDICAL CO., LTD. (TW) | 2020-03-03 | — | — | US | claimed |
| US-20190317339-A1 | CONTACT LENS PRODUCT | LARGAN MEDICAL CO., LTD. (TW) | 2019-10-17 | — | — | US | claimed |
| US-10371966-B2 | Contact lens product | LARGAN MEDICAL CO., LTD. (TW) | 2019-08-06 | — | — | US | claimed |
| US-20170227790-A1 | CONTACT LENS PRODUCT | LARGAN MEDICAL CO., LTD. (TW) | 2017-08-10 | — | — | US | claimed |
| EP-0396376-B1 | Polymerizable dye | BAUSCH & LOMB (US) | 1994-12-28 | — | — | EP | claimed |
| US-4997897-A | Unsaturated esters or amides of aminoanthraquinone dyes | BAUSCH & LOMB INCORPORATED (US) | 1991-03-05 | — | — | US | claimed |
| JP-3072576-A | — | — | None | — | — | JP | disclosed |
| US-20260147141-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-05-28 | — | — | US | disclosed |
| US-12631791-B2 | Multifunctional crosslinking agents and ophthalmic devices formed therefrom | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-05-19 | — | — | US | disclosed |
| US-20260109119-A1 | STABILIZED FORMULATIONS FOR CONTACT LENSES | COOPERVISION INTERNATIONAL LIMITED (GB) | 2026-04-23 | — | — | US | disclosed |
| US-6364934-B1 | IMPROVING OPTICAL QUALITY IN CONTACT LENSES BY FILTERING THE HYDROPHILIC AND HYDROPHOBIC MONOMERS THEREBY FINELY DISPERSING THEM AND ANY DISSOLVED GASES | BAUSCH & LOMB INCORPORATED | 2002-04-02 | — | — | US | disclosed |
| US-6359024-B2 | PHOTOPOLYMERIZATION; USING LIGHT SOURCE | BAUSCH & LOMB INCORPORATED | 2002-03-19 | — | — | US | disclosed |
| US-20010014704-A1 | METHOD FOR POLYMERIZING CONTACT LENSES | SOLTA MEDICAL IRELAND LIMITED (IE) | 2001-08-16 | — | — | US | disclosed |
| JP-H0372576-A | POLYMERIZABLE DYE | BAUSCH & LOMB INC | 1991-03-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | NPC1 3998/4885RAB9A 4835/4885LMNA 2948/4885 |
| US-12631791-B2 | Multifunctional crosslinking agents and ophthalmic devices formed therefrom | ILK, MACF1, RAD51 | NPC1 4753/4885RAB9A 1697/4885LMNA 301/4885 |
| US-20260147141-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES | EPCAM, STIM1, SMCHD1 | NPC1 1618/4885RAB9A 1823/4885LMNA 2741/4885 |
| US-20260109119-A1 | STABILIZED FORMULATIONS FOR CONTACT LENSES | POT1, TELO2, TST | NPC1 4567/4885RAB9A 4274/4885LMNA 905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.